Dr. Xu Jinsheng Nephrology


Consultant - Nephrologist , Experience: 18 Years

Book Appointment

About Doctor

Xu Jinsheng is now the Director of the 4thHospital of Hebei Medical University, Head of Nephrology Department, Secondary Professor, Chief Physician, Doctor of Medicine, Doctoral Supervisor, Academic Leader of Nephrology, Hebei Provincial Outstanding Expert, Young and Middle-aged Expert with Outstanding Contribution in Hebei, Member of the First National Hemopurification Expert Group.

Academic Part-time Jobs:Vice Chairman of Special Committee for Kidney Rehabilitation of Chinese Medical Doctor Association, Vice Chairman of Special Committee for Hemopurification of Chinese Research-oriented Hospital Association,Vice Chairman of Technical Committee for Hemopurification Equipment of China Association of Medical Equipment, Member of the Standing Committee of Hemopurification Branch of Chinese Hospital Association, Vice Chairman of Hemopurification Quality Control Union of Beijing-Tianjin-Hebei Region, Director of Hebei Professional Hemopurification Quality Management and Control Center,Chairman of Hemopurification Center Management Branch of Hebei Hospital Association,Chairman of Special Committee for Nephrology Medicine of Hebei Pharmaceutical Society,Chairman of Hemopurification Equipment and Material Branch of Hebei Clinical Medical Engineering Society,Designate Chairman of Nephrology Branch of Hebei Medical Association.

Hospital

Hebei Cancer Hospital, Hebei, China

Specialization

  • Nephrology

Procedures Performed

Research & Publications

Need help? Our team is ready to assist you.

We wish a speedy recovery of your dear and near one.

×
Start chat
We Are Online! Chat With Us!
Scan the code
Hello,

Welcome to CancerFax !

CancerFax is a pioneering platform dedicated to connecting individuals facing advanced-stage cancer with groundbreaking cell therapies like CAR T-Cell therapy, Gene therapy, TIL therapy, and clinical trials worldwide.

Let us know what we can do for you.

1) CAR T-Cell therapy
2) Gene therapy
3) Gamma-Delta T Cell therapy
4) TIL therapy
5) NK Cell therapy